1199790

Ultragenyx Pharmaceutical Inc. — FEI 3012208691

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 27, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Novato, CA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)